PMEL and melanoma: Similarly, our results proposed to combine PLA1A with other routine invasiveness diagnostic markers of melanoma: HMB-45, S-100 and Ki-67, with the hope that these markers, after proper standardization, might serve as a potent indicators in the prognosis and determination of the metastatic stage of melanoma51.